Both in Pharmaceuticals
Johnson & Johnson vs Bristol-Myers Squibb
Over the past year JNJ returned +46.7% and BMY returned +35.8%; their daily moves had a correlation of 0.45.
JNJ +46.7% BMY +35.8%Growth of $1, one year, split-adjusted
| Metric | JNJ | BMY |
|---|---|---|
| Price | $273.20 | $62.48 |
| Market cap | $657.68B | $127.71B |
| Today | −0.73% | +1.78% |
| 1 month | +5.6% | +1.7% |
| 6 months | +20.3% | +7.3% |
| Year to date | +32.0% | +15.8% |
| 1 year | +46.4% | +46.7% |
| Revenue growth (YoY) | +5.9% | +5.7% |
| Gross margin | 68.1% | 71.3% |
| Net margin | 0.8% | 25.6% |
| P/E (TTM) | 40.9× | 13.8× |
| Price / sales | 6.6× | 2.6× |
| Net cash | -$27.42B | -$32.05B |
| Dividend yield | 1.96% | 4.03% |
| Volatility (60d) | 23.4% | 27.3% |
| Short % of float | 0.7% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).